Additional file 2: of Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

Plasma AIS biomarker tau.xls. Value of tau as plasma AIS biomarker reflecting stroke severity and long-term outcome. Severity (NIHSS) or outcome at 12 months (mRS 12 m) were first dichotomized: patients with NIHSS scores ≤7 were pooled versus NIHSS >7, or with mRS scores 0–3 versus scores 4–6. ROC analysis was performed at all time points on both groups for tau, quantified by Simoa. Statistical significant AUC-values are depicted in bold font and underlined. (XLSX 11 kb)